
Cefectra S 250mg/125mg Injection
Marketer
Serbia Molecules Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefectra S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and proliferation. Administration must be overseen by a medical professional. Complete the prescribed dosage regimen; premature cessation may compromise efficacy. Common adverse reactions include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects or allergic responses (rash, pruritus, edema, dyspnea) immediately to your physician. Inform your doctor of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and hydration will aid recovery. Your doctor might order lab tests to monitor treatment response.
Uses of Cefectra S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefectra S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefectra S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefectra S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefectra S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefectra S 250mg/125mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Cefectra S 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefectra S (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Cefectra S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Nursing mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Cefectra S 250mg/125mg Injection can lead to drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefectra S 250mg/125mg Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Cefectra S 250mg/125mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Cefectra S 250mg/125mg Injection is unnecessary in patients experiencing mild to moderate liver dysfunction.
What if you forget to take Cefectra S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Cefectra S 250mg/125mg Injection, seek medical advice immediately.
Facts to Know About Cefectra S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
